In three independent mRNA microarray analyses [52-54], higher levels of PrP mRNA were significantly associated with estrogen receptor negative cancers consistent with the previously reported higher resistance to adjuvant chemotherapy in estrogen receptor negative and PrP positive cancers [14]. This evidence concerns the gene PRNP and cancer.